706
Participants
Start Date
July 6, 2019
Primary Completion Date
September 22, 2020
Study Completion Date
September 22, 2020
AXS-07
AXS-07 (MoSEIC meloxicam and rizatriptan) taken by mouth for the acute treatment of migraine.
Clinical Research Site, Manlius
Clinical Research Site, Williamsville
Clinical Research Site, Rochester
Clinical Research Site, Philadelphia
Clinical Research Site, Charlottesville
Clinical Research Site, High Point
Clinical Research Site, Charleston
Clinical Research Site, Mt. Pleasant
Clinical Research Site, Stockbridge
Clinical Research Site, Lake City
Clinical Research Site, Ormond Beach
Clinical Research Site, Jacksonville
Clinical Research Site, Birmingham
Clinical Research Site, Birmingham
Clinical Research Site, Orlando
Clinical Research Site, Hallandale
Clinical Research Site, Miami
Clinical Research Site, Lake Worth
Clinical Research Site, Tampa
Clinical Research Site, Ocoee
Clinical Research Site, Mobile
Clinical Research Site, Knoxville
Clinical Research Site, Memphis
Clinical Research Site, Louisville
Clinical Research Site, Columbus
Clinical Research Site, Cincinnati
Clinical Research Site, Ann Arbor
Clinical Research Site, Minneapolis
Clinical Research Site, Evanston
Clinical Research Site, Springfield
Clinical Research Site, Oklahoma City
Clinical Research Site, Austin
Clinical Research Site, Salt Lake City
Clinical Research Site, Phoenix
Clinical Research Site, Albuquerque
Clinical Research Site, Las Vegas
Clinical Research Site, Los Angeles
Clinical Research Site, Los Angeles
Clinical Research Site, Los Alamitos
Clinical Research Site, Canoga Park
Clinical Research Site, Encino
Clinical Research Site, Spring Valley
Clinical Research Site, San Diego
Clinical Research Site, Colton
Clinical Research Site, Walnut Creek
Clinical Research Site, Portland
Clinical Research Site, Salem
Clinical Research Site, Seattle
Clinical Research Site, Boston
Clinical Research Site, North Dartmouth
Clinical Research Site, Waltham
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY